• 2020 WedBush PacGrow Healthcare Conference
• Wednesday, August 12[th], 2020 from 12:35pm-1:05pm EDT

• This presentation will be webcast live and details will be available on www.irras.com

• H.C. Wainwright 22nd Annual Global Investment Conference

• September 14-16[th], 2020

• The company is hosting 1x1 meetings with investors

• Pareto Securities' Annual Healthcare Conference 2020 Stockholm

• September 2[nd], 2020 from 3pm-3:30pm CET
• This presentation will be webcast live and can be accessed by Pareto Securities' registered clients

About IRRAS
IRRAS is a global medical care company focused on delivering innovative medical solutions to improve the lives of critically ill patients. IRRAS designs, develops, and commercializes neurocritical care products that transform patient outcomes and decrease the overall cost of care by addressing complications associated with current treatment methodologies. IRRAS markets and sells its comprehensive, innovative IRRAflow and Hummingbird ICP Monitoring product lines to hospitals worldwide through its direct sales organization in the United States and select European countries as well as an international network of distribution partners.  
IRRAS maintains its headquarters in Stockholm, Sweden, with corporate offices in Munich, Germany, and San Diego, California, USA. For more information, please visit www.irras.com. 
IRRAS AB (publ) is listed on Nasdaq Stockholm (ticker: IRRAS).

For more information, please contact:

USA
Kleanthis G. Xanthopoulos, Ph.D.
CEO
ir@irras.com  

Europe
Sabina Berlin
CFO
+46 73 951 95 02
sabina.berlin@irras.com

The information was released for public disclosure, through the agency of the contact person above, on August 5, 2020 at 08:00 (CET).